Basic Information 【 display / non-display

MORITOKI Yuki

写真a

Affiliation

Hospital , Center for Medical Education and Training

Title

Specially-appointed Associate Professor

Research Fields, keywords

Autoimmune Liver Diseases, Primary Biliary Cholangitis, B lymphocytes, Simulation-Based Medical Education

Academic Background (Undergraduate Level) 【 display / non-display

  • Akita University   Faculty of Medicine   1999.03  Graduated

  • Kobe University   Faculty of Science   1992.03  Graduated

Academic Background (Graduate Level) 【 display / non-display

  • Tohoku University  Graduate School, Division of Medicine  Doctor's Degree Program  2006.03  Completed

History of going abroad to study 【 display / non-display

  • 2004.07
    -
    2009.03

    Division of Rheumatology, Allergy and Clinical Immunology, University of California Davis   Postgraduate research scholar, Postdoctoral research scholar

Professional Career On-Campus 【 display / non-display

  • 2019.07
    -
     

    Akita University   Hospital   Center for Medical Education and Training   Specially-appointed Associate Professor

  • 2014.10
    -
    2019.06

    Akita University   Hospital   Center for Medical Education and Training   Specially-appointed Lecturer

  • 2013.04
    -
    2014.09

    Akita University   Hospital   Medical Doctor Support Center   Specially-appointed Lecturer

  • 2011.04
    -
    2013.03

    Akita University   Hospital   Career Development Center   Specially-appointed Lecturer

  • 2011.01
    -
    2011.03

    Akita University   Hospital   Central Laboratory Division   Lecturer

display all >>

Acquisition Qualification 【 display / non-display

  • Doctor

  • Certified Healthcare Simulation Educator (CHSE) of SSH

 

Articles 【 display / non-display

  • Umbilical Catheterization training: Tissue hybrid versus synthetic trainer.

    Takahashi S, Ozawa Y, Nagasawa J, Ito Y, Ouchi G, Kabbur P, Moritoki Y, Berg BW.

    Pediatrics International   2019.05

  • Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcgammaR-Expressing Mice.

    Moritoki Y, Tsuneyama K, Nakamura Y, Kikuchi K, Shiota A, Ohsugi Y, Lian ZX, Zhang W, Yang GX, Ueki S, Takeda M, Omokawa A, Saga T, Saga A, Watanabe D, Miura M, Ueno Y, Leung PSC, Tanaka A, Gershwin ME, Hirokawa M.

    Front Immunol   2018.11

  • Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis

    Jin Q, Moritoki Y, Lleo A, Tsuneyama K, Invernizzi P, Moritoki H, Kikuchi K, Lian ZX, Hirschfield GM, Ansari AA, Coppel RL, Gershwin ME, Niu J.

    Hepatology   2012.05

  • Biochemical and immunologic effects of rituximab in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.

    Tsuda M, Moritoki Y, Lian ZX, Zhang W, Yoshida K, Wakabayashi K, Yang GX, Nakatani T, Vierling J, Lindor K, Gershwin ME, Bowlus CL.

    Hepatology   2012.02

  • B cells promote hepatic inflammation, biliary cyst formation, and salivary gland inflammation in the NOD.c3c4 model of autoimmune cholangitis.

    Moritoki Y, Tsuda M, Tsuneyama K, Zhang W, Yoshida K, Lian ZX, Yang GX, Ridgway WM, Wicker LS, Ansari AA, Gershwin ME.

    Cell Immunol.   2011.01

display all >>

Reviews 【 display / non-display

  • Pathological features of new animal models for primary biliary cirrhosis

    Tsuneyama K, Moritoki Y, Kikuchi K, Nakanuma Y.

    Int J Hepatol ( Hindawi )   2011.04

  • Murine models of autoimmune cholangitis.

    Ueno Y, Ambrosini YM, Moritoki Y, Ridgway WM, Gershwin ME.

    Curr Opin Gastroenterol. ( Wolters Kluwel )   2010.05

  • B cells and autoimmune liver diseases

    Moritoki Y, Lian ZX, Ohsugi Y, Ueno Y, Gershwin ME.

    Autoimmun Rev ( Elsevier )   2006.08

  • Proliferation and differentiation of cholangiocytes

    Moritoki Y., Ueno Y.

    KANTANSUI   2003.05